SENSEX NIFTY
74671.28 22419.95
941.12 (1.28%)
-150.40 (-0.67%)
 
Advisory for investors  I      FTP Login   I      List of AP   I      SMARTODR   I     Webmail

NOTICES

Heading View
  SEBI Circular No. CIR/MRD/DP/01/2014 Dated 7th January, 2014   Click here
  SEBI Circular No. SEBI/HO/MIRSD/MIRSD2/CIR/P/2016/95, Dated 26th September, 2016.   Click here
DETACH
Increase
Minus
Monday, April 29, 2024  SENSEX  : 74671.28  [+941.12]     -  Asian Paints : 2868.10   [+23.50]      Axis Bank : 1159.45   [+29.40]      Bajaj Finance : 6827.40   [+97.55]      Bajaj Finserv : 1595.45   [-1.65]      Bharti Airtel : 1333.25   [+7.75]      HCL Technologies : 1387.10   [-85.20]      HDFC Bank : 1528.80   [+19.05]      Hind. Unilever : 2226.95   [+5.45]      ICICI Bank : 1158.80   [+51.65]      IndusInd Bank : 1487.75   [+41.90]      Infosys : 1435.00   [+4.85]      ITC : 438.00   [-1.95]      JSW Steel : 896.00   [+9.40]      Kotak Mah. Bank : 1640.25   [+31.85]      Larsen & Toubro : 3633.90   [+31.60]      M & M : 2062.85   [+18.60]      Maruti Suzuki : 12695.75   [+8.70]      Nestle India : 2510.60   [+26.80]      NTPC : 363.10   [+7.35]      Power Grid Corpn : 293.70   [+1.60]      Reliance Industr : 2930.50   [+27.50]      St Bk of India : 826.15   [+24.75]      Sun Pharma.Inds. : 1521.95   [+17.70]      Tata Motors : 1000.45   [+1.10]      Tata Steel : 167.40   [+1.55]      TCS : 3870.60   [+57.75]      Tech Mahindra : 1288.80   [+11.35]      Titan Company : 3605.15   [+20.75]      UltraTech Cem. : 9962.25   [+262.05]      Wipro : 462.95   [-1.70]      
Hot Pursuit Back
Caplin Point rises on USFDA nod for eye drops
(16 Apr 2024, 11:02)
The approved ANDA is a generic therapeutic equivalent version of reference listed drug (RLD), Ocuflox Ophthalmic Solution of Allergan Inc.

Ofloxacin Ophthalmic Solution (eye drops) is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers.

According to IQVIA (IMS Health), Ofloxacin Ophthalmic Solution had US sales of approximately $52 million for the 12- month period ending December 2023.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company?s consolidated net profit jumped 30.1% to Rs 119.82 crore on 17% increase in revenue from operations to Rs 435.50 crore in Q3 FY24 over Q3 FY23.

Powered by Capital Market - Live News
 
Attention Investors: No need to issue cheques by investors while subscribing to IPO. just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. | Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.' "
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Clients: We are here with requesting you to submit your separate e-mail id to receive communications/reports, by submitting account modification form in this regards or if you have registered your family member e-mail id with us, please submit declaration in this regards. Further, if you have not registered e-mail id/mobile number with us, please register it by submitting account modification form which facilitates you to receive all the data/reports electronically. If you require any clarification, please feel free to call Mr. Hemant Shah on 9004603818 or email us at kyc@swcapital.in
Feedback | Back Office | Downloads | KYC | Disclaimer | Privacy Policy | Investor Grievances |
INVESTOR CHARTER |
INVESTOR CHARTER-STOCK BROKER INVESTOR CHARTER-DEPOSITORY PARTICIPANTS
Communique | Tariff Structure |
INVESTOR COMPLAINTS DETAILS|
Month End Month-Wise Year-Wise

SCORES|
E-Voting Links|
CDSL E-voting NSDL E-voting|
Opening A Account| Filing A Complaints
SW CAPITAL PVT LTD CIN No. : U67120MH1994PTC081512 | SW Capital Pvt. Ltd.> SEBI Regn. No :- NSE-CM/FO/CD- INZ000182531 | BSE-CM/FO/CD- INZ000182531 | CDSL DP : IN-DP-CDSL-272-2004
Copyright © 2011 -SW Capital Pvt Ltd. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)